Chun Yong

Chun Yong is a prominent figure in the field of diabetes management and technology. He currently holds two significant positions:

1. General Partner at Reach7 Diabetes Studios
2. CEO and Founder of Diasyst - Diabetes Simplified

Professional Background

Chun Yong has established himself as a leader in the diabetes technology sector. He founded Diasyst, a platform that aims to simplify diabetes management by providing in-depth analysis and insights. This innovative approach demonstrates his commitment to improving the lives of people with diabetes through technology.

Education and Early Career

Chun Yong has a background in Biomedical Engineering. During his time as a student in the Biomedical Engineering department, he stood out as an exceptional leader, initiating several important projects within the field.1

Current Roles and Initiatives

As the General Partner at Reach7 Diabetes Studios, Chun Yong is involved in fostering innovation and development in diabetes-related technologies and solutions.3 His work at Reach7 Diabetes Studios likely involves identifying and supporting promising startups and technologies in the diabetes space.

In his role as CEO of Diasyst, Chun leads efforts to simplify diabetes management through technology. The company's platform provides medication intelligence and in-depth analysis to improve diabetes care.2

Collaborations and Partnerships

Chun Yong has been actively involved in forming partnerships to enhance diabetes care. For example, in September 2022, he announced a partnership between Diasyst and CollaborateHealth to augment remote patient monitoring services with Diasyst's technology.4

Public Engagement

Chun has participated in podcasts and other public forums to discuss innovations in diabetes management. For instance, he appeared on the OverReaction podcast with Jeremy Bikman to discuss new approaches in diabetes care.3

Chun Yong's LinkedIn profile can be found under the username "chunyong", where more details about his professional experience and accomplishments may be available.